101 related articles for article (PubMed ID: 15863230)
1. Investigation into the effects of the novel antipsychotic ziprasidone on weight gain and reproductive function in female rats.
Fell MJ; Gibson R; McDermott E; Sisodia G; Marshall KM; Neill JC
Behav Brain Res; 2005 May; 160(2):338-43. PubMed ID: 15863230
[TBL] [Abstract][Full Text] [Related]
2. The effect of ziprasidone on body weight and energy expenditure in female rats.
Park S; Kim MS; Namkoong C; Park MH; Hong JP
Metabolism; 2012 Jun; 61(6):787-93. PubMed ID: 22209671
[TBL] [Abstract][Full Text] [Related]
3. Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.
Fell MJ; Marshall KM; Williams J; Neill JC
J Psychopharmacol; 2004 Jun; 18(2):149-55. PubMed ID: 15260902
[TBL] [Abstract][Full Text] [Related]
4. Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
Fell MJ; Neill JC; Marshall KM
Eur Neuropsychopharmacol; 2004 Oct; 14(5):385-92. PubMed ID: 15336300
[TBL] [Abstract][Full Text] [Related]
5. Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.
Fell MJ; Neill JC; Anjum N; Peltola LM; Marshall KM
J Psychopharmacol; 2008 Mar; 22(2):182-6. PubMed ID: 18308803
[TBL] [Abstract][Full Text] [Related]
6. Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats.
Fell MJ; Neill JC; Rao C; Marshall KM
Psychopharmacology (Berl); 2005 Nov; 182(4):499-507. PubMed ID: 16163524
[TBL] [Abstract][Full Text] [Related]
7. Using oral ziprasidone effectively: the food effect and dose-response.
Citrome L
Adv Ther; 2009 Aug; 26(8):739-48. PubMed ID: 19669631
[TBL] [Abstract][Full Text] [Related]
8. Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine.
Kalinichev M; Rourke C; Jones DN
Behav Pharmacol; 2006 May; 17(3):289-92. PubMed ID: 16572006
[TBL] [Abstract][Full Text] [Related]
9. Effects of risperidone, quetiapine and ziprasidone on ethanol withdrawal syndrome in rats.
Celikyurt IK; Kayir H; Ulak G; Erden FB; Ulusoy GK; Uzbay TI
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):528-36. PubMed ID: 21168466
[TBL] [Abstract][Full Text] [Related]
10. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.
Fell MJ; Anjum N; Dickinson K; Marshall KM; Peltola LM; Vickers S; Cheetham S; Neill JC
Psychopharmacology (Berl); 2007 Oct; 194(2):221-31. PubMed ID: 17581744
[TBL] [Abstract][Full Text] [Related]
11. Ziprasidone suppresses olanzapine-induced increases in ingestive behaviour in the rat.
Kirk SL; Neill JC; Jones DN; Reynolds GP
Eur J Pharmacol; 2004 Nov; 505(1-3):253-4. PubMed ID: 15556160
[TBL] [Abstract][Full Text] [Related]
12. Ziprasidone and aripiprazole attenuate olanzapine-induced hyperphagia in rats.
Snigdha S; Thumbi C; Reynolds GP; Neill JC
J Psychopharmacol; 2008 Jul; 22(5):567-71. PubMed ID: 18208914
[TBL] [Abstract][Full Text] [Related]
13. Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats.
Rachoń D; Vortherms T; Seidlová-Wuttke D; Wuttke W
Maturitas; 2008; 60(3-4):209-15. PubMed ID: 18691839
[TBL] [Abstract][Full Text] [Related]
14. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
Looije NA; Risovic V; Stewart DJ; Debeyer D; Kutney J; Wasan KM
J Pharm Pharm Sci; 2005 Aug; 8(3):400-8. PubMed ID: 16401390
[TBL] [Abstract][Full Text] [Related]
15. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
16. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight.
Malmlöf K; Zaragoza F; Golozoubova V; Refsgaard HH; Cremers T; Raun K; Wulff BS; Johansen PB; Westerink B; Rimvall K
Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415
[TBL] [Abstract][Full Text] [Related]
17. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
[TBL] [Abstract][Full Text] [Related]
18. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats.
Terry AV; Parikh V; Gearhart DA; Pillai A; Hohnadel E; Warner S; Nasrallah HA; Mahadik SP
J Pharmacol Exp Ther; 2006 Aug; 318(2):709-24. PubMed ID: 16702442
[TBL] [Abstract][Full Text] [Related]
19. Ziprasidone outcome and tolerability: a practical clinical trial with plasma drug levels.
Mauri MC; Colasanti A; Rossattini M; Volonteri LS; Dragogna F; Fiorentini A; Fiorentini A; Valli A; Papa P
Pharmacopsychiatry; 2007 May; 40(3):89-92. PubMed ID: 17541882
[TBL] [Abstract][Full Text] [Related]
20. Weight effects associated with antipsychotics: a comprehensive database analysis.
Parsons B; Allison DB; Loebel A; Williams K; Giller E; Romano S; Siu C
Schizophr Res; 2009 May; 110(1-3):103-10. PubMed ID: 19321312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
